Navigation Links
BioMotiv Secures $46 Million in Funding
Date:8/5/2013

CLEVELAND, Aug. 5, 2013 /PRNewswire-USNewswire/ -- BioMotiv, a drug development accelerator based in Cleveland, Ohio, today announced that it has increased its total capital from investors to $46 million, adding Nationwide Mutual Insurance Company and several individual investors to its founding investors, University Hospitals of Cleveland and the Harrington Family.  Nationwide Mutual Insurance Company also will appoint a representative to serve on the Board of Managers of BioMotiv. 

(Logo: http://photos.prnewswire.com/prnh/20130805/DC57374LOGO)

"BioMotiv is a new business model for accelerating breakthrough discoveries into medicines, aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv.  "This support from local institutions and investors provides the company a strong foundation on which to build nationally."

Launched last year, BioMotiv has established its organization and operations and attracted a world-renowned advisory board that includes several former heads of global pharmaceutical research and development organizations to manage a portfolio of promising drug technologies.  The company is affiliated with The Harrington Project for Discovery and Development, a $250 million national initiative initiated by University Hospitals.

"We license early-stage technologies and then develop them with the oversight of our experienced team and network of partners," said Shah.  BioMotiv has begun work on several promising technologies sourced from research institutions and industry sources.

BioMotiv continues to seek additional early-stage therapeutic technologies that are at the pre-clinical or early-clinical stage of development. 

About The Harrington Project

The Harrington Project for Discovery and Development is a $250 million national initiative to support the discovery and development of breakthrough discoveries by physician-scientists.  The Harrington Project, centered at University Hospitals Case Medical Center, is a new and powerful national model that addresses a set of challenges in advancing medicine through its innovative approach.  It includes the Harrington Discovery Institute and BioMotiv. The project, powered by a generous gift and investment from the Harrington family, successful entrepreneurs and recognized philanthropists in Cleveland, provides a comprehensive model to advance discoveries into development and to create novel therapies for patient care.

For more information about the Harrington Discovery Institute, go to: www.uhharringtondiscoveryinstitute.org.

For more information about BioMotiv, go to: www.BioMotiv.com.


'/>"/>
SOURCE BioMotiv
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMotiv Secures $21 million in Initial Funding
2. BioMotiv Names New Chief Executive Officer
3. Stark Medical Secures GSA Schedule Contract, Looks to Supply VA
4. NGM Biopharmaceuticals Secures $50 Million in Series C Financing to Advance its Portfolio of Novel Therapies for Diabetes and Obesity
5. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
6. SecureState Identifies Top 5 Vulnerabilities Facing Hospitals and Medical Device Manufactures
7. Aviir Secures Third $10 Million Financing Tranche To Fund Expanded Sales Of New Heart Risk Test
8. Chronic Kidney Disease: Reducing Risks of Progression-- Prismic Pharmaceuticals Secures Exclusive Licensing Rights
9. United Spinal Secures Victory in Protecting Access to Complex Rehab Technology in Washington State
10. Alimera Sciences Secures $20 Million Debt Facility
11. Henry Schein Secures $300 Million Of Committed Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016 MSD, a ... supply chain solutions to alternate site health care facilities, ... First Choice Medical Supply ("First Choice"), a privately held ... the skilled nursing and home health segments. We would ... This compelling transaction will deliver significant ...
(Date:12/9/2016)... 9, 2016 External Defibrillators, ... ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), ... Defibrillators The global defibrillators market ... of 5.3% from 2016-2020 and CAGR of 5.1% ... at a CAGR of 5.2% from 2016 to ...
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
Breaking Medicine Technology:
(Date:12/9/2016)... WA (PRWEB) , ... December 09, 2016 , ... ... financial planning assistance from offices in Pasco and Richland, is initiating a charity ... overcome serious injuries resulting from a recent automobile collision. , On October ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... Cellairis is ... and affordable repairs on iPhone , iPad and Samsung Galaxy devices ... Pearland Walmart in order to maximize convenience and accessibility for customers. While customers ...
(Date:12/9/2016)... Kentucky - Cincinnati, Ohio (PRWEB) , ... December ... ... in the production of miniature, folded, pharmaceutical inserts and outserts. As a ... Serialization Device. This addition will enable Flottman to individually code professional inserts ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I have ... "I used this old family recipe, which is meant to relieve gout and pain ... gave me a 12-hour energy boost every time. It relieved what VA doctors called ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund ... (NCADD) is recommending the film Whispering Spirits and its discussion guide for ... as an education tool in the war against teen drug abuse. NCADD is ...
Breaking Medicine News(10 mins):